Establishment of a children's Drugs and Therapeutics Committee to ensure evidence-based and cost-effective medical treatment for children.
Drugs and Therapeutics Committee
clinical pharmacology
formulary list
neonatal
paediatrics
Journal
British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
revised:
01
09
2023
received:
10
05
2023
accepted:
06
10
2023
pubmed:
26
10
2023
medline:
26
10
2023
entrez:
25
10
2023
Statut:
aheadofprint
Résumé
The prevalence of undocumented medical treatments among children is a significant issue, as well as many EU countries lack access to newly developed children-friendly medicines. Consequently, there is a pressing need for supplementary resources that can facilitate informed decision-making regarding children's medication. We therefore aim to describe the process of establishing a children's Drug and Therapeutics Committee (cDTC), as well as the preparing and implementation of recommendations for children in the capital region of Denmark. Following the guidelines outlined by the World Health Organization, we established a cDTC, and recommendations for paediatric medication practice were constructed from assessments of medication use patterns among children in the capital region between 2019 and 2021. The recommendations were meticulously crafted based on evaluation of the current marketing authorization landscape and existing best available evidence. In 2019, the capital region established the first cDTC supported by expert councils and an editorial board. A total of 2429 purchase item numbers covering 1 222 846 defined daily doses and 592 088 purchased packages covering 10 200 000 defined daily doses were identified in the secondary and primary sectors, respectively. Three comprehensive lists covering recommendations for newborns and children were published between 2021 and 2020 totaling 331 recommended pharmaceutical products. The recommendations primarily intended for use in the secondary healthcare sector were implemented through the revision of 38 paediatric- and six neonatal product ranges throughout capital region. In conclusion, recommendation lists for children governed by a cDTC provide a rational auxiliary tool that can be immediately implemented in the clinic.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Copenhagen University Hospital
Organisme : Copenhagen University Hospital
Informations de copyright
© 2023 British Pharmacological Society.
Références
Rishoej RM, Almarsdóttir AB, Christesen HT, Hallas J, Kjeldsen LJ. Medication errors in pediatric inpatients: a study based on a national mandatory reporting system. Eur J Pediatr. 2017;176(12):1697-1705. doi:10.1007/s00431-017-3023-8
Choonara I, Conroy S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf. 2002;25(1):1-5. doi:10.2165/00002018-200225010-00001
Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. SPAE. 1999;88(9):965-968. doi:10.1080/08035259950168469
Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54(6):665-670. doi:10.1046/j.1365-2125.2002.t01-3-01689.x
O'Hara K, Wright IMR, Schneider JJ, Jones AL, Martin JH. Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future. Br J Clin Pharmacol. 2015;80(6):1281-1288. doi:10.1111/bcp.12741
Sharma DC. Cough syrup deaths expose lax drug regulation in India. Lancet. 2022;400(10361):1395. doi:10.1016/S0140-6736(22)02026-8
European Commission. State of paediatric medicines in the EU. Accessed May 31, 2022. https://ec.europa.eu/health/system/files/2017-11/2017_childrensmedicines_report_en_0.pdf
European Medicines Agency. Paediatric regulation. Published September 17, 2018. Accessed May 31, 2022. https://www.ema.europa.eu/en/human-regulatory/overview/paediatric-medicines/paediatric-regulation
Toma M, Felisi M, Bonifazi D, et al. Paediatric medicines in Europe: the Paediatric regulation-is it time for reform? Front Med. 2021;8:593281. doi:10.3389/fmed.2021.593281
Mørk ML, Andersen JT, Lausten-Thomsen U, Gade C. The blind spot of pharmacology: a scoping review of drug metabolism in prematurely born children. Front Pharmacol. 2022;13:828010. doi:10.3389/fphar.2022.828010
Gade C, Trolle S, Mørk ML, et al. Massive presence of off-label medicines in Danish neonatal departments: a nationwide survey using national hospital purchase data. Pharmacol Res Perspect. 2023;11:e01037. doi:10.1002/prp2.1037
Lepola P, Wang S, Tötterman AM, Gullberg N, Harboe KM, Kimland E. Does the EU's Paediatric Regulation work for new medicines for children in Denmark, Finland, Norway and Sweden? A cross-sectional study. BMJ Paediatr Open. 2023;4(1):e000880. doi:10.1136/bmjpo-2020-000880
Sofat R, Cremers S, Ferner RE. Drug and therapeutics committees as guardians of safe and rational medicines use. Br J Clin Pharmacol. 2020;86(1):10-12. doi:10.1111/bcp.14088
Eriksen J, Gustafsson LL, Ateva K, et al. High adherence to the ‘wise list’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines. BMJ Open. 2017;7(4):e014345. doi:10.1136/bmjopen-2016-014345
NICE. BNF is only available in the UK. Accessed November 1, 2022. https://www.nice.org.uk/bnf-uk-only
Kinderformularium (Dutch Pediatric Formulary). Accessed June 22, 2022. Health E-Solutions. https://healthesolutions.nl/portfolio/kinderformularium-dutch-pediatric-formulary/
World Health Organization. Drug and therapeutics committees: a practical guide. World Health Organization; 2003. Accessed November 1, 2022. https://apps.who.int/iris/handle/10665/68553
Plet HT, Hallas J, Nielsen GS, Kjeldsen LJ. Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures. Basic Clin Pharmacol Toxicol. 2013;112(4):264-269. doi:10.1111/bcpt.12028
Aftale om Region Hovedstadens budget for 2021.pdf. Accessed October 25, 2022. https://www.regionh.dk/presse-og-nyt/pressemeddelelser-og-nyheder/Documents/Budget%202021_med_bilag_FINAL.pdf
Healthcare in Denmark: an overview. Ministry of Health; 2016.
WHO Collaboraing Centre for Drug Statistics Methodology. ATC/DDD Index. Accessed November 1, 2022. https://www.whocc.no/atc_ddd_index/
European Commission. Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668). Accessed June 22, 2022. https://www.ema.europa.eu/en/documents/scientific-guideline/annex-european-commission-guideline-excipients-labelling-package-leaflet-medicinal-products-human_en.pdf
European Medicines Agency. Human medicines: regulatory information. Published September 20, 2018. Accessed November 1, 2022. https://www.ema.europa.eu/en/human-medicines-regulatory-information
Produktresumeer-Søgeresultat. Accessed October 19, 2016. https://www.produktresume.dk/AppBuilder/search
Region Hovedstaden. Laegemiddelkomite. Accessed December 28, 2022. https://www.regionh.dk/til-fagfolk/Sundhed/Sundhedsfaglige-raad-og-komiteer/Sider/laegemiddelkomite-den-regionale.aspx
Børnebasislisten. Accessed October 25, 2022. https://www.sundhed.dk/sundhedsfaglig/information-til-praksis/hovedstaden/almen-praksis/laegemidler/bornebasisliste/
Danske Regioner. Danish Regions in English. Accessed August 5, 2022. https://www.regioner.dk/services/in-english
Green PE. The general practice formulary-its role in rational therapeutics. J R Coll Gen Pract. 1985;35(281):570-572.
Solu-Medrol, pulver og solvens til injektionsvaeske, opløsning 40 mg, 125 mg, 500 mg, 1 g.doc. Accessed June 19, 2022. https://view.officeapps.live.com/op/view.aspx?src=http%3A%2F%2Fspcweb.dkma.dk%2FSPCREPL%2FHuman%2FS%2FSolu-Medrol%2C%2520pulver%2520og%2520solvens%2520til%2520injektionsv%25c3%25a6ske%2C%2520opl%25c3%25b8sning%252040%2520mg%2C%2520125%2520mg%2C%2520500%2520mg%2C%25201%2520g.doc&wdOrigin=BROWSELINK